These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6386844)

  • 1. Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids.
    Verbrugh HA; Keane WF; Conroy WE; Peterson PK
    J Clin Microbiol; 1984 Aug; 20(2):199-203. PubMed ID: 6386844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.
    Kussmann M; Hauer S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1091-1098. PubMed ID: 29546637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro study of bacterial growth in continuous ambulatory peritoneal dialysis fluids.
    Sheth NK; Bartell CA; Roth DA
    J Clin Microbiol; 1986 Jun; 23(6):1096-8. PubMed ID: 3086376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis.
    Buggy BP; Schaberg DR; Swartz RD
    Am J Med; 1984 Jun; 76(6):1035-40. PubMed ID: 6731461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of clindamycin on the intracellular bactericidal capacity of human peritoneal macrophages.
    de Fijter CW; Verbrugh HA; Heezius HC; van der Meulen J; Oe PL; Donker AJ; Verhoef J
    J Antimicrob Chemother; 1990 Oct; 26(4):525-32. PubMed ID: 2254222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-calcium peritoneal dialysis fluid should not impact peritonitis rates in continuous ambulatory peritoneal dialysis.
    de Fijter CW; Oe LP; Heezius EC; Donker AJ; Verbrugh HA
    Am J Kidney Dis; 1996 Mar; 27(3):409-15. PubMed ID: 8604711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.
    Kussmann M; Schuster L; Wrenger S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Perit Dial Int; 2016 11-12; 36(6):662-668. PubMed ID: 27680756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.
    Halstead DC; Guzzo J; Giardina JA; Geshan AE
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1553-6. PubMed ID: 2510594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
    Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA
    Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of bacterial biofilms on silastic catheter materials in peritoneal dialysis fluid.
    Dasgupta MK; Ward K; Noble PA; Larabie M; Costerton JW
    Am J Kidney Dis; 1994 May; 23(5):709-16. PubMed ID: 8172213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
    Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting Staphylococcus epidermidis growth in peritoneal dialysis solutions.
    McDonald WA; Watts J; Bowmer MI
    J Clin Microbiol; 1986 Jul; 24(1):104-7. PubMed ID: 3722356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes.
    Pascual A; Tsukayama D; Kovarik J; Gekker G; Peterson P
    Eur J Clin Microbiol; 1987 Apr; 6(2):152-7. PubMed ID: 2954817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glucose in dialysis fluid on antibacterial defence in the peritoneal cavity.
    Calame W; Hendrickx RJ; Namavar F; Oe LP; Beelen RH
    J Infect; 1995 May; 30(3):227-33. PubMed ID: 7673747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of peritoneal dialysis solutions on rifampin action against Staphylococcus epidermidis in the fluid and biofilm phases of growth.
    Richards GK; Gagnon RF; Obst G; Kostiner GB
    Perit Dial Int; 1993; 13 Suppl 2():S341-4. PubMed ID: 8399605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of dialysis fluid on the susceptibility of Staphylococcus epidermidis biofilms to rifampin.
    Gagnon RF; Richards GK; Kostiner GB; Morcos R
    Adv Perit Dial; 1993; 9():183-6. PubMed ID: 8105919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic tolerance of peritoneal bacterial isolates in dialysis fluids.
    Zelenitsky S; Franczuk C; Fine A; Ariano R; Harding G
    J Antimicrob Chemother; 2002 May; 49(5):863-6. PubMed ID: 12003985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial aggregation in relation to peritoneal dialysis.
    Reid G; Schwarz-Faulkner S; McGroarty JA; Bruce AW
    Perit Dial Int; 1990; 10(1):21-4. PubMed ID: 2085576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modulation by fresh and spent peritoneal dialysis fluids of antibiotic kinetics directed against Staphylococcus epidermidis biofilms.
    Richards GK; Kostiner GB; Gagnon RF
    Adv Perit Dial; 1992; 8():246-9. PubMed ID: 1361798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid.
    Shalit I; Welch DF; San Joaquin VH; Marks MI
    Antimicrob Agents Chemother; 1985 Jun; 27(6):908-11. PubMed ID: 3927837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.